2022-11-15
2022-11-25
2022-12-11
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2023-06-27
持续布局CGT,阿斯利康与Revvity达成合作,获得基因编辑技术
2023-05-19
2023-05-13
2024-01-18
药明康德一细胞基因治疗生产基地关闭,“卖水人”CDMO泡沫将破?
2023-03-29
2023-04-29
2022-11-30
2022-11-29